title: Current management of muscle-invasive bladder cancer.
abstract: Management of muscle-invasive bladder cancer (MIBC) has changed little in the last twenty years. The gold standard treatment is still cystectomy, but it has a significant negative impact on quality of life. Bladder-preservation strategies can be used in some cases but patient selection for this approach remains unclear. New chemotherapy and biologic agents in combination with surgery or radiotherapy could improve results and these possibilities are currently under investigation.
authors: Radiation Oncology Department, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Universitat Autònoma de Barcelona, Spain. gsancho@santpau.cat
authors: G
authors: G
authors: Sancho
authors: P
authors: P
authors: Maroto
authors: J
authors: J
authors: Palou
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D019042:Muscle Neoplasms / Q000628:therapy*; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000628:therapy*